Abdominal PainDETECT_AcuteNCT05651360
Diagnostic Performance of Low-Dose CT for Acute Abdominal Conditions
An observational study of Abdominal Pain and Acute Pain, run by Oslo University Hospital at 2 sites in 2 countries.
Trial summary
The goal of this non-inferiority observational study is to assess the diagnostic performance of low-dose CT with deep learning image reconstruction (DLIR) in adult participants with acute abdominal conditions. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Abdominal Pain, Acute Pain, Acute Cholecystitis
- What is being tested?
- low-dose CT
- How many people
- 246 participants
- Where
- 2 sitesin 2 countries
- Study dates
- 7 Dec 2022to 10 Jul 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: primary care clinic; university hospital
Who may be able to join
- Patients under evaluation for an acute abdominal condition who are referred to CT of the abdomen and pelvis.
- Age >18 years
- The patients must be able to give their oral and written consent to study participation.
Who cannot join
- Contraindications regarding contrast enhanced CT examinations like known iodinated contrast media adverse reactions or claustrophobia.
- Pregnancy.
Trial locations and contacts
2 sites in 2 countries.
2 sites in 2 countries
About this study
Official title: Diagnostic Performance of Deep Learning Image Reconstruction in Low Dose CT for the Detection of Acute Abdominal Conditions
The goal of this non-inferiority observational study is to assess the diagnostic performance of low-dose CT with deep learning image reconstruction (DLIR) in adult participants with acute abdominal conditions. The main research question is:
- Can low-dose CT with DLIR achieve the same diagnostic performance as standard CT for the diagnosis of acute abdominal conditions.
Read more
Participants will be examined with an additional low-dose CT directly after the standard CT. Participant will be their own controls.
Registration record updated on 15.05.2026 to correct entry errors (correction of sample size calculation now resulting in a larger sample size than previously stated, mixed-effects logistic regression was used for analysis of the diagnostic accuracy) so that the record reflects the study protocol in effect before enrollment of the first participant.
Read the detailed description
Background Computed Tomography (CT) has become an essential tool in modern clinical medicine. With widespread availability, a rapid increase in the use of CT imaging has been observed over the last decades. With the associated increase in radiation exposure, the potential increased risk for radiation-induced malignancy has become a public health concern. This is especially true for CT scans of the abdomen and pelvis which currently account for 50% of the collective CT dose. As the benefit of dose reduction in general is offset by deterioration of image quality, technological advances to reduce radiation dose without compromising image quality are aspired in clinical practice.
In CT-image reconstruction, filtered back projection (FBP) has been the dominant image reconstruction technique algorithm since the early 1970s, complemented by the first commercial iterative reconstruction (IR) algorithms in 2009.
A novel deep learning image reconstruction (DLIR) algorithm received clinical approval in 2019 (TrueFidelity, GE Healthcare, Milwaukee, WI). Other vendor-specific algorithms for deep learning image reconstruction are also emerging (AiCE, Canon Medical Systems, Otawara, Japan). As explained by a technical white paper, having been trained with high-dose and low-dose FBP datasets across phantom and patient cases, the DLIR algorithm strives to suppress image noise without compromising image quality. The use of deep learning image reconstruction has demonstrated potential for improved image quality and dose reduction without shifting noise texture.
For patients with acute abdominal conditions, CT of the abdomen and pelvis is considered the best first- or second-line diagnostic approach. For these patients a fast and accurate diagnosis is of great importance to avoid treatment delay and subsequent complications such as gastrointestinal perforation in case of appendicitis or diverticulitis. On the other hand, it is also important to avoid unnecessary surgical intervention and the related complications. A possible low-dose CT protocol must therefore provide a non-inferior diagnostic performance to facilitate fast diagnosis and avoid overtreatment and inconclusive examinations.
Promising results have been reported regarding low-dose CT examinations with model-based IR and dose reduction of up to 75-80%. However, with the introduction of DLIR even further dose reduction seems feasible. Our own results from an image quality perception study with DLIR indicate that a dose reduction of up to 92.5% compared to standard CT might preserve acceptable diagnostic image quality (yet unpublished work).
On this basis, the purpose of this study is to assess the diagnostic performance of low-dose CT with DLIR for the diagnosis of acute abdominal conditions in a non-inferiority setting with a large sample size provided by two major trauma centers in northern Europe.
Aims
Primary:
To evaluate the diagnostic performance for acute abdominal conditions of contrast enhanced low-dose CT with DLIR "TrueFidelity" (TF) compared to standard full-dose CT.
Secondary:
To evaluate technical and perceived image quality (qualitatively and quantitatively).
Ethics
Approval will be obtained from the regional ethics committee and the institutions data protection officer.
Written informed consent will be obtained from all participants. This project will be in accordance with the Helsinki Declaration.
Risks Minimal risks exist due to a slight increase in radiation exposure. The additional radiation exposure of 27.5% is within the national variation of radiation exposure from CT exams performed for corresponding clinical tasks. The investigators estimated the mean additional effective dose to 1.5 mSv which corresponds to about 4 months with natural background radiation exposure in Norway (4.1 mSv/year). The additional radiation exposure translates into a theoretical excess lifetime risk of deadly radiation induced cancer between 0.004 - 0.03%. The clinical risks from this exposure are considered to be minimal/not significant.
Material and Methods The study will be registered at ClinicalTrials.gov prior to initiation. Study methods and results will be reported in agreement with the Standards for Reporting of Diagnostic Accuracy Studies (STARD) statement of 2015. It should be noted that the STARD-AI Steering Group is preparing an AI-specific extension. If these STARD-AI guidelines are published before end of study, the findings will also be reported in accordance herewith. To compensate for AI specific elements not addressed in STARD, the investigators will, when relevant, rely on the Checklist for Artificial Intelligence in Medical Imaging (CLAIM) which is modelled after the STARD guideline.
Pilot A study pilot including 10 patients divided equally between Oslo and Odense will be performed to allow for testing of study logistics and adjustments of the radiation dose level of the low-dose CT.
Examination protocol / imaging Examinations will be carried out according to local routine procedures and established CT protocols (CT scanner: GE Revolution).
In addition to the CT with standard examination protocol a low-dose CT scan will be performed, not exceeding 30% radiation dose of the standard CT. Low-dose CT images will be reconstructed with TF high. The low dose CT will be performed directly after the standard CT to avoid bias from differences in the timing of the contrast phase.
Location and local study population The study will be carried out as a multicenter study involving Oslo and Odense with prospective data collection.
The estimated total study population will be divided equally between the two Hospitals.
Image evaluation The low-dose CT will not be used for diagnostic purposes or patient treatment. Image evaluation and comparison will be conducted separated from clinical routine workflow.
All low-dose CT exams will be evaluated independently by two resident radiologists and by two experienced radiologists specialized in abdominal radiology with more than 10 years of experience in abdominal CT. The readers will be blinded for all information from previous exams, the primary CT report, any finding by the other readers, all treatment related information and for the final diagnosis.
They will have access to clinical referrals and laboratory tests performed prior to the original CT examination. Image evaluation will be performed in the radiologists' clinical environment using diagnostic monitors.
In the outcome analysis, the diagnosis for each patient from low dose CT will be compared to the original radiological diagnosis based on full dose CT.
For intra reader agreement a random selection from 10% of the cases will be presented twice to each reader.
Technical image quality is assessed by positioning regions of interest (ROI) in a homogeneous segment of the portal vein, adjacent normal liver parenchyma aorta, erector spinae muscles and in the subcutaneous fat. Contrast-to-Noise Ratio (CNR) will be calculated.
Perceived image quality will be assessed by at least two radiologists on a Likert-type scale along image quality criteria based on the European guidelines for image quality in abdominal CT.
Statistics Dedicated statistical software like Stata and SPSS will be used for analysis of study data. The alpha significance level will be set to 5% and 95% confidence intervals will be used. Kappa statistics will be used for inter and intra reader agreement. Logistic regression will be used for image quality assessment. Appropriate parametric or non-parametric tests will be used for evaluation of numeric variables. The diagnostic performance will be defined by sensitivity, specificity, positive and negative predictive value. Significant differences in sensitivity and specificity will be determined by mixed-effects logistic regression.
Power calculation and sample size A non-inferiority study design will be used to show non-inferiority regarding the diagnostic performance of the low-dose CT compared to standard CT.
The non-inferiority margin was set at 6%. Sample size was estimated to be N≈200 based on the following assumptions: 95% CI width of 10% (±5%), expected SDCT sensitivity of p=0.90, disease prevalence of 0.7, evaluation of each exam by two readers, and a binomial distribution. To adjust for clustering, we applied a design effect (DE): DE=1+(m-1)×ρ, where m=2 represents the mean number of readers per case and we assumed an intra-patient class correlation coefficient of ρ=1 (conservative assumption). Formula:
n_exams = 2n_participants=(4 z_0.975^2 * p(1-p)* DE)/((CI width)^2×prevalence)
- Being tested
- low-dose CT
- Keywords
- Computed Tomography, Deep learning image reconstruction, Low-dose, Diagnostic performance, Diagnosis
- Medical subject headings
- Abdominal Pain, Acute Pain, Cholecystitis, Acute, Appendicitis, Pancreatitis, Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
low-dose CTDiagnostic test
Low-dose CT scan will be performed, not exceeding 30% radiation dose of the standard CT. Low-dose CT images will be reconstructed with TrueFidelity high. The low-dose CT will be performed directly after the standard CT to avoid bias from differences in the timing of the contrast phase.
| Study group | Role | What they receive |
|---|---|---|
| Abdominal Pain | Participants under evaluation for an acute abdominal condition who are referred to CT of the abdomen and pelvis. Receives: Diagnostic Test: low-dose CT |
What is being measured
The primary outcome is the main question the study is designed to answer.
Diagnostic performance of low-dose CT
Diagnostic performance of low-dose CT compared to standard CT according to ICD 10 diagnosis.
Diagnostic performance measured in terms of:
Sensitivity, derived from mixed-effects logistic regression.
Measured: 6 to 12 months
Secondary outcomes (7)
Diagnostic performance
Diagnostic performance measured in terms of: Specificity, positive predictive value, negative predictive value, and accuracy derived from mixed-effects logistic regression.
Measured: 6 to 12 month
Radiation dose
Compare radiation dose; low-dose vs standard CT:
Radiation dose measured in terms of DLP and CTDIvol.
Measured: 6 to 12 months
Reading time.
Reading time difference between low-dose CT and standard CT.
Measured: 6 to 12 month
Perceived image quality
Compare perceived image quality; low-dose vs standard CT:
Perceived image quality scored on a ordinal, 5-point Likert scale (at least two readers).
Measured: 6 to 12 months
Image quality - noise
Compare technical image quality; low-dose vs standard CT:
Image noise in terms of standard deviation within a region of interest (ROI); numerical as Hounsfield unit (HU), several points of measurement.
Measured: 6 to 12 months
Image quality - contrast-to-noise ratio
Compare technical image quality; low-dose vs standard CT:
Contrast-to-noise ratio; numerical, several points of measurement. Calculated according to:
CNR=(│〖HU〗_Kidney - 〖HU〗_(Water )│)/√((〖SD〗_Kidney 2 + 〖SD〗_Water 2 )/2)
Measured: 6 to 12 months
Diagnoses
Descriptive exploration of diagnoses among patients referred to CT examinations; diagnoses according to ICD 10.
Measured: 6 to 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Dec 2022
- Study start7 Dec 2022
- Primary completion10 Jul 2023
- Study completion10 Jul 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (29)Papers the sponsor has linked to this study.
- Other trials for Abdominal PainStudies of the same condition, open and under way.
- More trials run by Oslo University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 246 participants (actual)
Sponsor and investigators
- Lead sponsor
- Oslo University Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Odense University Hospital
- Responsible party
- Principal investigator, Anselm Schulz,MD, Oslo University Hospital
- Investigators
- Anselm Schulz, PhD, Principal investigator, Oslo University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05651360
- Sponsor's protocol ID
- PVO ref. 22/11840
- Other IDs
- 22/11840, 468490
- Acronym
- DETECT_Acute
- Status last verified
- Jun 2026
- First submitted
- 15 Nov 2022
- Last updated
- 8 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: IPD will not be shared due to legal and privacy Issues.
Publications
Brenner DJ, Hall EJ. Computed tomography--an increasing source of radiation exposure. N Engl J Med. 2007 Nov 29;357(22):2277-84. doi: 10.1056/NEJMra072149. No abstract available.
PubMed 18046031Novelline RA, Rhea JT, Rao PM, Stuk JL. Helical CT in emergency radiology. Radiology. 1999 Nov;213(2):321-39. doi: 10.1148/radiology.213.2.r99nv01321.
PubMed 10551209OECD. Computed tomography (CT) exams. 2018.
Berrington de Gonzalez A, Mahesh M, Kim KP, Bhargavan M, Lewis R, Mettler F, Land C. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med. 2009 Dec 14;169(22):2071-7. doi: 10.1001/archinternmed.2009.440.
PubMed 20008689Mettler FA Jr, Thomadsen BR, Bhargavan M, Gilley DB, Gray JE, Lipoti JA, McCrohan J, Yoshizumi TT, Mahesh M. Medical radiation exposure in the U.S. in 2006: preliminary results. Health Phys. 2008 Nov;95(5):502-7. doi: 10.1097/01.HP.0000326333.42287.a2.
PubMed 18849682Pan X, Sidky EY, Vannier M. Why do commercial CT scanners still employ traditional, filtered back-projection for image reconstruction? Inverse Probl. 2009 Jan 1;25(12):1230009. doi: 10.1088/0266-5611/25/12/123009.
PubMed 20376330Beister M, Kolditz D, Kalender WA. Iterative reconstruction methods in X-ray CT. Phys Med. 2012 Apr;28(2):94-108. doi: 10.1016/j.ejmp.2012.01.003. Epub 2012 Feb 10.
PubMed 22316498Hsieh JL, E.; Nett, B.; Tang, J.; Thibault JB.; Sahney, S. A new era of image reconstruction: TrueFidelity. Technical white paper on deep learning image reconstruction. 2019.
Akagi M, Nakamura Y, Higaki T, Narita K, Honda Y, Zhou J, Yu Z, Akino N, Awai K. Deep learning reconstruction improves image quality of abdominal ultra-high-resolution CT. Eur Radiol. 2019 Nov;29(11):6163-6171. doi: 10.1007/s00330-019-06170-3. Epub 2019 Apr 11.
PubMed 30976831Jensen CT, Liu X, Tamm EP, Chandler AG, Sun J, Morani AC, Javadi S, Wagner-Bartak NA. Image Quality Assessment of Abdominal CT by Use of New Deep Learning Image Reconstruction: Initial Experience. AJR Am J Roentgenol. 2020 Jul;215(1):50-57. doi: 10.2214/AJR.19.22332. Epub 2020 Apr 14.
PubMed 32286872Njolstad T, Schulz A, Godt JC, Brogger HM, Johansen CK, Andersen HK, Martinsen ACT. Improved image quality in abdominal computed tomography reconstructed with a novel Deep Learning Image Reconstruction technique - initial clinical experience. Acta Radiol Open. 2021 Apr 9;10(4):20584601211008391. doi: 10.1177/20584601211008391. eCollection 2021 Apr.
PubMed 33889427Solomon J, Lyu P, Marin D, Samei E. Noise and spatial resolution properties of a commercially available deep learning-based CT reconstruction algorithm. Med Phys. 2020 Sep;47(9):3961-3971. doi: 10.1002/mp.14319. Epub 2020 Jul 6.
PubMed 32506661Greffier J, Hamard A, Pereira F, Barrau C, Pasquier H, Beregi JP, Frandon J. Image quality and dose reduction opportunity of deep learning image reconstruction algorithm for CT: a phantom study. Eur Radiol. 2020 Jul;30(7):3951-3959. doi: 10.1007/s00330-020-06724-w. Epub 2020 Feb 25.
PubMed 32100091Brady SL, Trout AT, Somasundaram E, Anton CG, Li Y, Dillman JR. Improving Image Quality and Reducing Radiation Dose for Pediatric CT by Using Deep Learning Reconstruction. Radiology. 2021 Jan;298(1):180-188. doi: 10.1148/radiol.2020202317. Epub 2020 Nov 17.
PubMed 33201790Larson DB, Johnson LW, Schnell BM, Salisbury SR, Forman HP. National trends in CT use in the emergency department: 1995-2007. Radiology. 2011 Jan;258(1):164-73. doi: 10.1148/radiol.10100640. Epub 2010 Nov 29.
PubMed 21115875
Study at a glance
From the registry record, last updated by the sponsor on 8 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Diagnostic Performance of Deep Learning Image Reconstruction in Low Dose CT for the Detection of Acute Abdominal Conditions
- ClinicalTrials.gov ID
- NCT05651360
- Acronym / sponsor ID
- DETECT_Acute / PVO ref. 22/11840
- Keywords
- Computed Tomography, Deep learning image reconstruction, Low-dose, Diagnostic performance, Diagnosis
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 246 participants (actual)
- Lead sponsor
- Oslo University HospitalUniversity, hospital or other
- Collaborators
- Odense University Hospital
- Study start
- 7 Dec 2022 (actual)
- Primary completion
- 10 Jul 2023 (actual)
- Study completion
- 10 Jul 2023 (actual)
- First posted
- 15 Dec 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this non-inferiority observational study is to assess the diagnostic performance of low-dose CT with deep learning image reconstruction (DLIR) in adult participants with acute abdominal conditions. The main research question is:
- Can low-dose CT with DLIR achieve the same diagnostic performance as standard CT for the diagnosis of acute abdominal conditions.
Participants will be examined with an additional low-dose CT directly after the standard CT. Participant will be their own controls.
Registration record updated on 15.05.2026 to correct entry errors (correction of sample size calculation now resulting in a larger sample size than previously stated, mixed-effects logistic regression was used for analysis of the diagnostic accuracy) so that the record reflects the study protocol in effect before enrollment of the first participant.
Detailed description
Background Computed Tomography (CT) has become an essential tool in modern clinical medicine. With widespread availability, a rapid increase in the use of CT imaging has been observed over the last decades. With the associated increase in radiation exposure, the potential increased risk for radiation-induced malignancy has become a public health concern. This is especially true for CT scans of the abdomen and pelvis which currently account for 50% of the collective CT dose. As the benefit of dose reduction in general is offset by deterioration of image quality, technological advances to reduce radiation dose without compromising image quality are aspired in clinical practice.
In CT-image reconstruction, filtered back projection (FBP) has been the dominant image reconstruction technique algorithm since the early 1970s, complemented by the first commercial iterative reconstruction (IR) algorithms in 2009.
A novel deep learning image reconstruction (DLIR) algorithm received clinical approval in 2019 (TrueFidelity, GE Healthcare, Milwaukee, WI). Other vendor-specific algorithms for deep learning image reconstruction are also emerging (AiCE, Canon Medical Systems, Otawara, Japan). As explained by a technical white paper, having been trained with high-dose and low-dose FBP datasets across phantom and patient cases, the DLIR algorithm strives to suppress image noise without compromising image quality. The use of deep learning image reconstruction has demonstrated potential for improved image quality and dose reduction without shifting noise texture.
For patients with acute abdominal conditions, CT of the abdomen and pelvis is considered the best first- or second-line diagnostic approach. For these patients a fast and accurate diagnosis is of great importance to avoid treatment delay and subsequent complications such as gastrointestinal perforation in case of appendicitis or diverticulitis. On the other hand, it is also important to avoid unnecessary surgical intervention and the related complications. A possible low-dose CT protocol must therefore provide a non-inferior diagnostic performance to facilitate fast diagnosis and avoid overtreatment and inconclusive examinations.
Promising results have been reported regarding low-dose CT examinations with model-based IR and dose reduction of up to 75-80%. However, with the introduction of DLIR even further dose reduction seems feasible. Our own results from an image quality perception study with DLIR indicate that a dose reduction of up to 92.5% compared to standard CT might preserve acceptable diagnostic image quality (yet unpublished work).
On this basis, the purpose of this study is to assess the diagnostic performance of low-dose CT with DLIR for the diagnosis of acute abdominal conditions in a non-inferiority setting with a large sample size provided by two major trauma centers in northern Europe.
Aims
Primary:
To evaluate the diagnostic performance for acute abdominal conditions of contrast enhanced low-dose CT with DLIR "TrueFidelity" (TF) compared to standard full-dose CT.
Secondary:
To evaluate technical and perceived image quality (qualitatively and quantitatively).
Ethics
Approval will be obtained from the regional ethics committee and the institutions data protection officer.
Written informed consent will be obtained from all participants. This project will be in accordance with the Helsinki Declaration.
Risks Minimal risks exist due to a slight increase in radiation exposure. The additional radiation exposure of 27.5% is within the national variation of radiation exposure from CT exams performed for corresponding clinical tasks. The investigators estimated the mean additional effective dose to 1.5 mSv which corresponds to about 4 months with natural background radiation exposure in Norway (4.1 mSv/year). The additional radiation exposure translates into a theoretical excess lifetime risk of deadly radiation induced cancer between 0.004 - 0.03%. The clinical risks from this exposure are considered to be minimal/not significant.
Material and Methods The study will be registered at ClinicalTrials.gov prior to initiation. Study methods and results will be reported in agreement with the Standards for Reporting of Diagnostic Accuracy Studies (STARD) statement of 2015. It should be noted that the STARD-AI Steering Group is preparing an AI-specific extension. If these STARD-AI guidelines are published before end of study, the findings will also be reported in accordance herewith. To compensate for AI specific elements not addressed in STARD, the investigators will, when relevant, rely on the Checklist for Artificial Intelligence in Medical Imaging (CLAIM) which is modelled after the STARD guideline.
Pilot A study pilot including 10 patients divided equally between Oslo and Odense will be performed to allow for testing of study logistics and adjustments of the radiation dose level of the low-dose CT.
Examination protocol / imaging Examinations will be carried out according to local routine procedures and established CT protocols (CT scanner: GE Revolution).
In addition to the CT with standard examination protocol a low-dose CT scan will be performed, not exceeding 30% radiation dose of the standard CT. Low-dose CT images will be reconstructed with TF high. The low dose CT will be performed directly after the standard CT to avoid bias from differences in the timing of the contrast phase.
Location and local study population The study will be carried out as a multicenter study involving Oslo and Odense with prospective data collection.
The estimated total study population will be divided equally between the two Hospitals.
Image evaluation The low-dose CT will not be used for diagnostic purposes or patient treatment. Image evaluation and comparison will be conducted separated from clinical routine workflow.
All low-dose CT exams will be evaluated independently by two resident radiologists and by two experienced radiologists specialized in abdominal radiology with more than 10 years of experience in abdominal CT. The readers will be blinded for all information from previous exams, the primary CT report, any finding by the other readers, all treatment related information and for the final diagnosis.
They will have access to clinical referrals and laboratory tests performed prior to the original CT examination. Image evaluation will be performed in the radiologists' clinical environment using diagnostic monitors.
In the outcome analysis, the diagnosis for each patient from low dose CT will be compared to the original radiological diagnosis based on full dose CT.
For intra reader agreement a random selection from 10% of the cases will be presented twice to each reader.
Technical image quality is assessed by positioning regions of interest (ROI) in a homogeneous segment of the portal vein, adjacent normal liver parenchyma aorta, erector spinae muscles and in the subcutaneous fat. Contrast-to-Noise Ratio (CNR) will be calculated.
Perceived image quality will be assessed by at least two radiologists on a Likert-type scale along image quality criteria based on the European guidelines for image quality in abdominal CT.
Statistics Dedicated statistical software like Stata and SPSS will be used for analysis of study data. The alpha significance level will be set to 5% and 95% confidence intervals will be used. Kappa statistics will be used for inter and intra reader agreement. Logistic regression will be used for image quality assessment. Appropriate parametric or non-parametric tests will be used for evaluation of numeric variables. The diagnostic performance will be defined by sensitivity, specificity, positive and negative predictive value. Significant differences in sensitivity and specificity will be determined by mixed-effects logistic regression.
Power calculation and sample size A non-inferiority study design will be used to show non-inferiority regarding the diagnostic performance of the low-dose CT compared to standard CT.
The non-inferiority margin was set at 6%. Sample size was estimated to be N≈200 based on the following assumptions: 95% CI width of 10% (±5%), expected SDCT sensitivity of p=0.90, disease prevalence of 0.7, evaluation of each exam by two readers, and a binomial distribution. To adjust for clustering, we applied a design effect (DE): DE=1+(m-1)×ρ, where m=2 represents the mean number of readers per case and we assumed an intra-patient class correlation coefficient of ρ=1 (conservative assumption). Formula:
n_exams = 2n_participants=(4 z_0.975^2 * p(1-p)* DE)/((CI width)^2×prevalence)
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Abdominal Pain | – | Diagnostic Test: low-dose CTParticipants under evaluation for an acute abdominal condition who are referred to CT of the abdomen and pelvis. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- primary care clinic; university hospital
Key inclusion criteria (3 listed)
- Patients under evaluation for an acute abdominal condition who are referred to CT of the abdomen and pelvis.
- Age >18 years
- The patients must be able to give their oral and written consent to study participation.
Key exclusion criteria (2 listed)
- Contraindications regarding contrast enhanced CT examinations like known iodinated contrast media adverse reactions or claustrophobia.
- Pregnancy.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| low-dose CTLow-dose CT scan will be performed, not exceeding 30% radiation dose of the standard CT. Low-dose CT images will be reconstructed with TrueFidelity high. The low-dose CT will be performed directly after the standard CT to avoid bias from differences in the timing of the contrast phase. | Diagnostic test | Abdominal Pain |
Primary outcome
Diagnostic performance of low-dose CT
Time frame: 6 to 12 months
Diagnostic performance of low-dose CT compared to standard CT according to ICD 10 diagnosis. Diagnostic performance measured in terms of: Sensitivity, derived from mixed-effects logistic regression.
7 secondary outcomes
Diagnostic performance
Time frame: 6 to 12 month
Radiation dose
Time frame: 6 to 12 months
Reading time.
Time frame: 6 to 12 month
Perceived image quality
Time frame: 6 to 12 months
Image quality - noise
Time frame: 6 to 12 months
Image quality - contrast-to-noise ratio
Time frame: 6 to 12 months
Diagnoses
Time frame: 6 to 12 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jun 2026.
- Background: PubMed 18046031Brenner DJ, Hall EJ. Computed tomography--an increasing source of radiation exposure. N Engl J Med. 2007 Nov 29;357(22):2277-84. doi: 10.1056/NEJMra072149. No abstract available.
- Background: PubMed 10551209Novelline RA, Rhea JT, Rao PM, Stuk JL. Helical CT in emergency radiology. Radiology. 1999 Nov;213(2):321-39. doi: 10.1148/radiology.213.2.r99nv01321.
- BackgroundOECD. Computed tomography (CT) exams. 2018.
- Background: PubMed 20008689Berrington de Gonzalez A, Mahesh M, Kim KP, Bhargavan M, Lewis R, Mettler F, Land C. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med. 2009 Dec 14;169(22):2071-7. doi: 10.1001/archinternmed.2009.440.
- Background: PubMed 18849682Mettler FA Jr, Thomadsen BR, Bhargavan M, Gilley DB, Gray JE, Lipoti JA, McCrohan J, Yoshizumi TT, Mahesh M. Medical radiation exposure in the U.S. in 2006: preliminary results. Health Phys. 2008 Nov;95(5):502-7. doi: 10.1097/01.HP.0000326333.42287.a2.
- Background: PubMed 20376330Pan X, Sidky EY, Vannier M. Why do commercial CT scanners still employ traditional, filtered back-projection for image reconstruction? Inverse Probl. 2009 Jan 1;25(12):1230009. doi: 10.1088/0266-5611/25/12/123009.
- Background: PubMed 22316498Beister M, Kolditz D, Kalender WA. Iterative reconstruction methods in X-ray CT. Phys Med. 2012 Apr;28(2):94-108. doi: 10.1016/j.ejmp.2012.01.003. Epub 2012 Feb 10.
- BackgroundHsieh JL, E.; Nett, B.; Tang, J.; Thibault JB.; Sahney, S. A new era of image reconstruction: TrueFidelity. Technical white paper on deep learning image reconstruction. 2019.
- Background: PubMed 30976831Akagi M, Nakamura Y, Higaki T, Narita K, Honda Y, Zhou J, Yu Z, Akino N, Awai K. Deep learning reconstruction improves image quality of abdominal ultra-high-resolution CT. Eur Radiol. 2019 Nov;29(11):6163-6171. doi: 10.1007/s00330-019-06170-3. Epub 2019 Apr 11.
- Background: PubMed 32286872Jensen CT, Liu X, Tamm EP, Chandler AG, Sun J, Morani AC, Javadi S, Wagner-Bartak NA. Image Quality Assessment of Abdominal CT by Use of New Deep Learning Image Reconstruction: Initial Experience. AJR Am J Roentgenol. 2020 Jul;215(1):50-57. doi: 10.2214/AJR.19.22332. Epub 2020 Apr 14.
- Background: PubMed 33889427Njolstad T, Schulz A, Godt JC, Brogger HM, Johansen CK, Andersen HK, Martinsen ACT. Improved image quality in abdominal computed tomography reconstructed with a novel Deep Learning Image Reconstruction technique - initial clinical experience. Acta Radiol Open. 2021 Apr 9;10(4):20584601211008391. doi: 10.1177/20584601211008391. eCollection 2021 Apr.
- Background: PubMed 32506661Solomon J, Lyu P, Marin D, Samei E. Noise and spatial resolution properties of a commercially available deep learning-based CT reconstruction algorithm. Med Phys. 2020 Sep;47(9):3961-3971. doi: 10.1002/mp.14319. Epub 2020 Jul 6.
- Individual participant dataSharing planned: No. IPD will not be shared due to legal and privacy Issues.
Related trials for Abdominal Pain
Recruiting
Effects of a Prebiotic-Probiotic Combination on Constipation Symptoms and Quality of Life
Constipation, Abdominal Pain
RecruitingPhase 2
REctus Sheath Trial
Acute Pain, Postoperative Pain, Acute
Recruiting
Comparing Two Laparoscopic Techniques for Hernia Repair in Children
Inguinal Hernia
Not yet recruiting
Lumbar ESP Block Versus TAP Block for Postoperative Pain Control in Children Undergoing Open Inguinal Hernia Repair
Inguinal Hernia, Postoperative Pain
Recruiting
Tramadol Versus Morphine for Postoperative Pain Relief Following Laparoscopic Abdominal Surgery
Multimodal Analgesia, Tramadol
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anselm Schulz, PhD principal investigator
Oslo University Hospital
2 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Abdominal Pain and Acute Pain, run by Oslo University Hospital at 2 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Denmark, Norway. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Diagnostic performance of low-dose CT (time frame: 6 to 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05651360, which also lists 29 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2026.